Satoshi Kano

10PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 08, 2026
Validation of the 9th Edition of the UICC TNM classification and the prognostic impact of nodal spread in salivary gland cancer.

Satoshi Kano, Takayoshi Suzuki, Nayuta Tsushima

|Sep 22, 2025
Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan.

Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi

|Sep 01, 2025
Author's reply to "Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer".

Satoshi Kano, Ichiro Kinoshita, Hirotoshi Dosaka-Akita

|Mar 27, 2025
Improved local control and survival outcomes with RADPLAT in T4 oropharyngeal cancer: a retrospective study.

Satoshi Kano, Takayoshi Suzuki, Daisuke Yoshida

|Jun 28, 2024
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.

Yoshitaka Honma, Nobuya Monden, Keisuke Yamazaki

|Apr 22, 2024
SlicerPIT: software development and implementation for planning and image-guided therapy in photoimmunotherapy.

Takayoshi Suzuki, Satoshi Kano, Masanobu Suzuki

Pageof 2